“…However, it (i.e., CS nanoparticles or molecular fragments) is not the major long-term release component from composites, unlike the aforementioned inorganic, plant-derived agents, animal-derived agents, and microorganism-derived antimicrobials. Generally, CS undergoes premodification, such as sulfation, , carboxymethylation, acylation, or other in situ chemical modifications, , processing to nanoscale, , or integration with other biomass materials such as PLA, , cellulose, , and alginate . Next, the treated CS is combined with other antimicrobial agents through encapsulation, loading, cross-linking, and other technologies to finally form various antimicrobial microcapsules, ,, films, ,, coatings, ,, or gels ,,,, with slow- or controlled-release functions.…”